A citation-based method for searching scientific literature

Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson, David A Henry. BMJ 2017
Times Cited: 1749







List of co-cited articles
163 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
16

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
14

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
13

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
12

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
11

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.
Beverley J Shea, Jeremy M Grimshaw, George A Wells, Maarten Boers, Neil Andersson, Candyce Hamel, Ashley C Porter, Peter Tugwell, David Moher, Lex M Bouter. BMC Med Res Methodol 2007
10

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
8

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
8

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
7

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
7

ROBIS: A new tool to assess risk of bias in systematic reviews was developed.
Penny Whiting, Jelena Savović, Julian P T Higgins, Deborah M Caldwell, Barnaby C Reeves, Beverley Shea, Philippa Davies, Jos Kleijnen, Rachel Churchill. J Clin Epidemiol 2016
520
7

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.
Beverley J Shea, Candyce Hamel, George A Wells, Lex M Bouter, Elizabeth Kristjansson, Jeremy Grimshaw, David A Henry, Maarten Boers. J Clin Epidemiol 2009
6

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
6


GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
6

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
6

Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
6

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
5

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
5

Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach.
Edoardo Aromataris, Ritin Fernandez, Christina M Godfrey, Cheryl Holly, Hanan Khalil, Patraporn Tungpunkom. Int J Evid Based Healthc 2015
410
5

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
5


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. Ann Intern Med 2009
4

AGREE II: advancing guideline development, reporting and evaluation in health care.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Francoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Jeremy Grimshaw, Steven E Hanna,[...]. CMAJ 2010
4

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews.
Alison Booth, Mike Clarke, Gordon Dooley, Davina Ghersi, David Moher, Mark Petticrew, Lesley Stewart. Syst Rev 2012
489
4

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.
Lazaros Belbasis, Vanesa Bellou, Evangelos Evangelou, John P A Ioannidis, Ioanna Tzoulaki. Lancet Neurol 2015
313
4

Systematic review finds overlapping reviews were not mentioned in every other overview.
Dawid Pieper, Sunya-Lee Antoine, Tim Mathes, Edmund A M Neugebauer, Michaela Eikermann. J Clin Epidemiol 2014
158
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Open Med 2009
4

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
4

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
4

PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement.
Jessie McGowan, Margaret Sampson, Douglas M Salzwedel, Elise Cogo, Vicki Foerster, Carol Lefebvre. J Clin Epidemiol 2016
949
4

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
4

The GRADE Working Group clarifies the construct of certainty of evidence.
Monica Hultcrantz, David Rind, Elie A Akl, Shaun Treweek, Reem A Mustafa, Alfonso Iorio, Brian S Alper, Joerg J Meerpohl, M Hassan Murad, Mohammed T Ansari,[...]. J Clin Epidemiol 2017
184
4


Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability.
Rita Banzi, Michela Cinquini, Marien Gonzalez-Lorenzo, Valentina Pecoraro, Matteo Capobussi, Silvia Minozzi. J Clin Epidemiol 2018
33
9

Plea for routinely presenting prediction intervals in meta-analysis.
Joanna IntHout, John P A Ioannidis, Maroeska M Rovers, Jelle J Goeman. BMJ Open 2016
412
3

A re-evaluation of random-effects meta-analysis.
Julian P T Higgins, Simon G Thompson, David J Spiegelhalter. J R Stat Soc Ser A Stat Soc 2009
3

Validation of an index of the quality of review articles.
A D Oxman, G H Guyatt. J Clin Epidemiol 1991
512
3

GRADE guidelines: 2. Framing the question and deciding on important outcomes.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, David Atkins, Jan Brozek, Gunn Vist, Philip Alderson, Paul Glasziou, Yngve Falck-Ytter, Holger J Schünemann. J Clin Epidemiol 2011
916
3

PRISMA harms checklist: improving harms reporting in systematic reviews.
Liliane Zorzela, Yoon K Loke, John P Ioannidis, Su Golder, Pasqualina Santaguida, Douglas G Altman, David Moher, Sunita Vohra. BMJ 2016
224
3

Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses.
Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, Lefkos T Middleton, John P A Ioannidis, Evangelos Evangelou. Alzheimers Dement 2017
108
3

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
3

An exploratory test for an excess of significant findings.
John P A Ioannidis, Thomas A Trikalinos. Clin Trials 2007
314
3

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
3

Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action.
Maurizio S Tonetti, Søren Jepsen, Lijian Jin, Joan Otomo-Corgel. J Clin Periodontol 2017
280
3

A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool.
Robert C Lorenz, Katja Matthias, Dawid Pieper, Uta Wegewitz, Johannes Morche, Marc Nocon, Olesja Rissling, Jacqueline Schirm, Anja Jacobs. J Clin Epidemiol 2019
41
7

An introduction to overviews of reviews: planning a relevant research question and objective for an overview.
Harriet Hunt, Alex Pollock, Pauline Campbell, Lise Estcourt, Ginny Brunton. Syst Rev 2018
82
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.